Latest News about ARGX
Recent news which mentions ARGX
Argenx Seeks FDA Nod For Its Flagship Neuromuscular Treatment Formulated For Subcutaneous Injection
September 21, 2022
From Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
August 11, 2022
From Benzinga
From Benzinga
Argenx's Vyvgart To 'Achieve Blockbuster Status,' This Analyst Says With 6% Price Target Hike
July 29, 2022
Tickers
ARGX
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
This is what you should do in the stock market now, according to three 2022 fund-award winners
April 07, 2022
From MarketWatch
From Benzinga
From Benzinga
Piper Comments On Increased Interest To Invest In Arcturus, 'Incrementally Positive' On Argenx
March 22, 2022
From Benzinga
Argenx's Subcutaneous Efgartigimod At Par With Intravenous Administration In Neuromuscular Disorder
March 22, 2022
From Benzinga
From Benzinga
Earnings Scheduled For March 3, 2022
March 03, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.